Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

D-Wave Quantum’s $42 Million Backlog and $588 Million War Chest Set the Stage for a Pivotal June

Rodolfo Hanigan by Rodolfo Hanigan
May 16, 2026
in Uncategorized
0
D-Wave Quantum Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

The first quarter produced two opposing realities for D-Wave Quantum. Reported revenue tumbled 81 percent to $2.9 million, undershooting analyst estimates and triggering a selloff that erased roughly 7 percent on Friday alone. Yet beneath that top-line disappointment, new bookings surged nearly 2,000 percent year-over-year to $33.4 million, pushing the company’s backlog of performance obligations past $42 million — a figure that already exceeds the total revenue expected for all of 2025.

The result is a stock torn between near-term pain and long-term promise. D-Wave’s shares last changed hands in New York at $20.35, while European trading saw them slip further to €17.48 — below the 200-day moving average and with a relative strength index of roughly 35, sitting in oversold territory. Year to date, the position has fallen about 27 percent.

Operating costs were the primary drag on the bottom line, jumping 125 percent to $56.5 million. The acquisition of Quantum Circuits was the main culprit, though a $28.5 million tax benefit from that deal partially offset the impact. Even so, the net loss widened to $18.4 million from $5.4 million in the year-ago period. Subscription revenue still managed to grow 15 percent and professional services rose 26 percent, signaling that the underlying demand story remains intact.

That demand is concentrated in two large contracts. Florida Atlantic University ordered a system worth $20 million, and an undisclosed Fortune 100 company signed a two-year cloud agreement valued at $10 million. Together, they helped propel the bookings explosion that has become the central focus for bulls.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Analysts have responded by trimming price targets but holding firm on their ratings. Mizuho lowered its target to $29 while keeping an outperform call. Canaccord cut to $41 but maintained a buy. Jefferies’ Kevin Garrigan held his $45 target unchanged, citing “clearly identifiable demand.” Among the 13 analysts covering D-Wave, the consensus price objective stands at $34.77 — implying roughly 70 percent upside from the last New York close. Not one analyst currently recommends selling.

The balance sheet provides another layer of comfort. D-Wave ended the quarter with $588.4 million in cash and marketable securities, a 93 percent increase year-over-year. That war chest gives management the financial flexibility to pursue an ambitious technology roadmap: a system with roughly 175 dual-rail qubits, a design for a 1,000-qubit machine by 2028, and a target of 100 logical qubits — widely viewed as the threshold for genuine quantum utility — by 2032.

Investors will get a deeper look at that strategy on June 1, when D-Wave holds its first-ever investor day at the New York Stock Exchange under the banner “The D-Wave Difference.” Executives are also scheduled to appear at conferences hosted by J.P. Morgan, TD Cowen and Baird through early June, and a user conference in London on June 18 will showcase real-world applications.

For the second and third quarters, management forecasts per-share losses of $0.08 in each period, with revenue expected to climb from $6.26 million to $12.85 million. The pivotal question heading into June: whether the record order surge can convert into recognizable revenue at that pace — and whether the market’s patience will hold until it does.

Ad

D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from June 14 delivers the answer:

The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

D-Wave Quantum: Buy or sell? Read more here...

Tags: D-Wave Quantum
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

June 14, 2026
BMW Stock
Automotive & E-Mobility

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock
Analysis

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Next Post
Take-Two Stock

Take-Two Interactive: Losses Hit $4 Billion, but GTA VI Pre-Order Leak Spurs 11% Rally Ahead of Earnings

The Shovel Sellers Are Winning the AI Gold Rush

The Shovel Sellers Are Winning the AI Gold Rush

Kontron Stock

Kontron’s Defense Boom Masks a Cash Drain That Only a Sale Can Fix

Recommended

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

5 months ago
Blackrock Stock

BlackRock’s Global Strategy: Dividend Payouts and Market Expansion

9 months ago
D-Wave Quantum Stock

D-Wave Quantum: A Story of High Ambition Amidst Financial Crosscurrents

3 months ago
Ooma Stock

Ooma Stock: A Clash Between Analyst Optimism and Insider Selling

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

OHB’s Free Float Squeeze Nears a Release as KKR Exit and Rocket Flight Converge

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

by Rodolfo Hanigan
June 14, 2026
0

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a...

BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026
Amazon Stock

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans
  • Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com